Reuters logo
BRIEF-Oncomed Pharma reports new data presented at American Association for Cancer Research
April 5, 2017 / 12:22 PM / 5 months ago

BRIEF-Oncomed Pharma reports new data presented at American Association for Cancer Research

April 5 (Reuters) - Oncomed Pharmaceuticals Inc:

* Oncomed Pharma-phase 1b study data of tarextumab in extensive-stage small cell lung cancer show changes in ctcs appear to correlate with os outcomes

* Oncomed Pharma- in series of preclinical studies, anti-rspo3 with paclitaxel chemo showed synergistic anti-tumor activity in tumors with rspo3 translocations

* Oncomed Pharma- preparing to file ind application with U.S. FDA during first half of 2017 for its novel gitrl-fc trimer immuno-oncology agent Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below